In PDAC, apart from four key driver genetic mutations (KRAS, CDKN2A/p16, TP53, SMAD4), other mutations in inherited susceptibility genes, e.g. BRCA2, MLH1, are risk factors for pancreatic cancer [3]. This evidence concerns the gene TP53 and pancreatic neoplasm.